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Abstract
Background: Hepatitis C virus (HCV) poses a growing threat to global health as it often leads to serious liver
diseases and is one of the primary causes for liver transplantation. Currently, no vaccines are available to prevent
HCV infection and clinical treatments have limited success. Since HCV has a small proteome, it relies on many host
cell proteins to complete its life cycle. In this study, we used a non-directed phenyl sulfonate ester probe (PS4≡)t o
selectively target a broad range of enzyme families that show differential activity during HCV replication in Huh-7
cells.
Results: The PS4≡ probe successfully targeted 19 active proteins in nine distinct protein families, some that were
predominantly labeled in situ compared to the in vitro labeled cell homogenate. Nine proteins revealed altered
activity levels during HCV replication. Some candidates identified, such as heat shock 70 kDa protein 8 (or HSP70
cognate), have been shown to influence viral release and abundance of cellular lipid droplets. Other differentially
active PS4≡ targets, such as electron transfer flavoprotein alpha, protein disulfide isomerase A5, and nuclear
distribution gene C homolog, constitute novel proteins that potentially mediate HCV propagation.
Conclusions: These findings demonstrate the practicality and versatility of non-directed activity-based protein
profiling (ABPP) to complement directed methods and accelerate the discovery of altered protein activities
associated with pathological states such as HCV replication. Collectively, these results highlight the ability of in situ
ABPP approaches to facilitate the identification of enzymes that are either predominantly or exclusively labeled in
living cells. Several of these differentially active enzymes represent possible HCV-host interactions that could be
targeted for diagnostic or therapeutic purposes.
Background
The hepatitis C virus (HCV) is the major causative
agent of hepatitis that affects over three percent of the
global population [1]. With no vaccines yet available
and clinical treatments that have only limited success,
many HCV-infected individuals develop chronic hepati-
tis which eventually progresses into liver steatosis, cir-
rhosis and hepatocellular carcinoma. HCV is the leading
cause of liver disease and transplantation [2]. As the
HCV genome is a single-stranded RNA molecule of
only ~9.6 kb (Figure 1A) that encodes for ten mature
viral proteins, HCV relies heavily on host factors for its
propagation. During cell entry, HCV E1 and E2 viral
proteins interact with four known host receptors CD81,
claudin-1, SRB1, and occludin [3]. Unpackaging is fol-
lowed by the synthesis of the HCV polypeptide by host
cell ribosomes that is subsequently processed into ten
viral proteins by host cellular signal peptidase, signal
peptide peptidase, and viral proteases NS2 and NS3/4A
[4]. Host-mediated post-translational modifications, such
as glycosylation of E1 and E2 [5], phosphorylation of
NS5A [6], as well as the direct interaction with host cell
geranylgeranylated FBL2 protein [7] and liver microRNA
miR-122 [8,9], are also deemed essential for viral protein
maturation and proper viral infectivity.
High throughput techniques,s u c ha sg e n ee x p r e s s i o n
profiling and proteomic approaches have led to the identi-
fication of several host-viral interactions [10,11]. However,
* Correspondence: John.Pezacki@nrc-cnrc.gc.ca
† Contributed equally
1Steacie Institute for Molecular Sciences, National Research Council Canada,
Ottawa, Ontario, K1A 0R6, Canada
Singaravelu et al. Proteome Science 2010, 8:5
http://www.proteomesci.com/content/8/1/5
© 2010 Singaravelu et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.some host cell factors involved in HCV propagation are
likely regulated both by post-translational modifications
and association with cofactors and regulatory proteins, for
which conventional abundance-based genomic and pro-
teomic techniques provide no direct information. Activity-
based protein profiling (ABPP) was developed to provide a
direct insight into changes in catalytic activity of enzyme
classes in complex proteomes [12-14] and to annotate pre-
viously unknown enzymatic functions of proteins [15].
ABPP employs active site-directed covalent probes that
consist of small molecule inhibitors linked to reporter tags
[12] that exploit conserved mechanistic features of their
target enzyme superfamily. Examples of ABPP probes
includes fluorophosphonates, acyloxymethyl ketones, and
amino acid coupled quinolimine methides that target ser-
ine hydrolases [16] and proteases [17,18]. We have pre-
viously applied some of these directed probes to study the
differential activity of host cell proteases during HCV
replication [19].
Although directed ABPP is effective for targeting
enzymes with known covalent inhibitors, there is a lack
of such cognate inhibitors for many enzyme classes. To
extend the number of enzyme classes addressable by
ABPP, non-directed probes were designed through the
screening of large libraries of small molecule inhibitors
against complex proteomes for activity-dependent pro-
tein reactivity [20,21]. Non-directed sulfonate ester [20],
a-chloroacetamide [22], and spiroepoxide [23] probes
were successfully used to target a wider range of protein
candidates through their reactivity with numerous
enzyme families. Herein, we applied activity-based pro-
filing using a non-directed phenyl sulfonate ester (PS4≡)
probe [20] to examine a wider range of enzyme families
involved in HCV replication.
Results and discussion
Characterization of non-directed activity based labeling
Directed ABPP probes have successfully targeted over a
dozen of different enzyme classes [24,25]. However, due
to the lack of cognate affinity labels, numerous enzymes
remain beyond the reach of directed ABPP. In this
study, we investigated the ability of ABPP approaches
using the non-directed PS4≡ probe to profile enzyme
activity in Huh-7 cells harboring the genotype 1b HCV
subgenomic replicon RNA (Figure 1) [26,27]. The selec-
tion of the PS4≡ probe was based on its activity-based
reactivity towards a large but manageable fraction of the
proteome (over half a dozen distinct enzyme families
are known to be targeted) [21,28] and on its relatively
small size, which should minimize non-covalent probe-
protein interactions and allow cellular uptake and distri-
bution for in situ labeling.
To achieve in-gel fluorescence detection of the labeled
protein candidates, a rhodamine dye was coupled to an
azide group for a subsequent conjugation via Huisgen’s
1,3-dipolar cycloaddition (’click’ chemistry) with the
alkyne group on the probe (Figure 1C). The configura-
tion of both bioorthogonal coupling partners, the alkyne
on PS4≡ and the azide on the rhodamine reporter
(RhN3), was chosen over the reverse position of func-
tional groups of the cycloaddition reaction (i.e. PSN3
and Rh≡)a st h ef i r s tc o n f i g u r a t i o np r o v e dt os i g n i f i -
cantly minimize non-specific labeling of abundant pro-
teins [28] (Figure 2).
The PS4≡ probe specificity was determined in vitro
with the isolated proteome of Huh-7 cells resuspended
in sodium phosphate buffer, for which the optimal label-
ing condition was observed to be 20 μM for one hour at
37°C (Figure 2A). At this concentration, the heat dena-
tured proteome revealed minimal non-specific reactivity
while displaying maximal sensitivity (Figures 2A, 3A-C).
At first glance, the PS4≡ probe had a unique fluores-
cence labeling profile (Figure 3) when compared with
amino acid coupled quinolimine methide probes in
H u h - 7c e l l s[ 1 9 ] .F i v es p o t s( F i g u r e3 G ,# 1 ,2 ,3 ,4 ,9 ) ,
comprising isomerases and chaperones (Table 1), dis-
played a significant differential activity in vitro between
naïve Huh-7 cells and those stably replicating HCV,
highlighting the importance of the PS4≡ non-specific
probe to complement directed ABPP for providing a
broader assessment of the differentially active proteome
between control cells and cells replicating HCV RNA.
In situ PS4≡ labeling increases the number of ABPP hits
An additional advantage of the PS4≡ probe is conferred
by its small molecular size for in situ ABPP. This, in turn,
allows the labeling of active enzymes in their native sub-
cellular environment to provide the most physiologically
relevant enzymatic profile. The in situ conditions were
optimized by varying the PS4≡ concentration in the cel-
lular media to obtain a fluorograph of similar banding
pattern, fluorescence intensity, and minimal background
as to the in vitro labeling. Under normalized labeling
conditions (in situ labeling for 1 hour with 100 μMi n
cell culture media; in vitro labeling for 1 hour with 20
μM probe in 1 mg/mL soluble proteome), the in situ
fluorescent labeling profile in Huh-7 cells (Figure 4) was
found quantitatively comparable to the in vitro profile
(Figure 3), as judged by the fluorescent spot intensity of
both profiles (Figure 4E) and taking into consideration
the silver stained gels as loading controls (Figures 3D-F
and 4C-D, 200 μgo fp r o t e o m el o a d e dp e rg e l ) .T h e
increased concentration of PS4≡ required for in situ
labeling could be attributed to cellular uptake as the
probe is thought to enter the cell via passive diffusion.
Although some of the proteins were labeled equally in
vitro and in situ, the latter resulted in some proteins that
were predominantly labeled in situ when compared to the
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Page 2 of 15Figure 1 Structure and protocol of the PS4≡ probe used in vitro and in situ to target the active Huh-7 proteome during HCV
replication. (A) Schematic representations of the HCV genome and the bi-cistronic (pFK-I389neo/NS3-3’/5.1) subgenomic replicon used in this
study (NS, non-structural proteins). (B) Northern analysis of HCV and b-actin (as a loading control) RNA (upper two blots) and detection of HCV
NS3, HCV NS5A, and b-tubulin (as a loading control) proteins by western blotting (lower three blots) in naïve Huh-7 human hepatoma cell lines
and in Huh-7 cells stably replicating HCV (HCV). (C) Scheme of the ABPP protocol used to identify phenyl sulfonate ester (PS4≡) targets. The
active proteome of naïve Huh-7 cells (not shown) or Huh-7 stably expressing the HCV replicon was labeled through a nucleophilic (Nu) residue
within the active site of the enzyme targeted by the reactive group of the PS4≡ probe. After isolation, the labeled proteome was conjugated
with the rhodamine azide reporter tag (RhN3) via the Huisgen’s 1,3-dipolar cycloaddition and separated by two-dimensional gel electrophoresis.
The fluorescently tagged proteins were identified by LC-MS/MS.
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Page 3 of 15cell homogenate (Figure 4E, spots # 2, 3, 4, 6, 7, 8, 10, 11,
18 and 19), which validates previous observations [28].
These enzymes included: a chaperone (heat shock protein
70), one isomerase (protein disulfide isomerase A1), two
ion-binding proteins (alpha 2-HS-glycoprotein and
nucleobindin), one electron transport protein (electron
transfer flavoprotein alpha), one hydrolase (ATP synthase
beta), and two transferases (quinolinate phosphoribosyl-
transferase and purine nucleoside phosphorylase) (Table
1). The decreased in vitro labeling of some proteins may
be attributed to the homogenate obtained by physical dis-
ruption of the Huh-7 cells for in vitro ABPP, altering the
concentration and subcellular distribution of endogenous
inhibitors/activators and protein-protein interactions
Figure 2 In vitro and in situ PS4≡ probe condition optimization for labeling the active proteomes from Huh-7 cells. (A) Active
proteomes isolated from naïve Huh-7 cells were treated at 37°C for 60 min with various concentrations of substrate based probes (PS4≡) either
with or without a denaturing preheating step (Δ = 100°C, 5 min), subjected to click chemistry with RhN3, separated by SDS/PAGE
electrophoresis, and visualize by in-gel fluorescence scanning. The in vitro optimal PS4≡ concentration with the strongest signal from the active
proteome and least non-specific binding from the denatured proteome was determined to be 20 μM. (B) In situ optimal labeling conditions for
the naïve Huh-7 proteome to give the strong and similar banding patterns as experiments conducted in vitro was determined to be an hour
incubation of 100 μM of PS4≡ probe in cell culture media. Non-specific fluorescence was observed to be negligible when either the PS4≡ probe
or RhN3 was omitted.
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Page 4 of 15needed for enzymatic activity [29]. Such physiologically
disruptive effects would explain the significant reduction
in ABPP labeling in vitro for ATP synthase beta (Figure
4E, spot 8); moreover, membrane disruption through pro-
teome isolation likely resulted in the loss of the proton
gradient needed for the conformational change of the b-
subunits of the transmembrane enzyme. This would pre-
vent the subsequent release of the ATP product and sig-
nificantly abolishing the enzyme’s hydrolase activity [30].
The enhanced labeling of some protein targets in situ
could also be attributed to the uneven subcellular distribu-
tion of the probe taken by cells, which could lead to the
enrichment of the probe in certain cellular organelles and
disproportionately enhance protein labeling [28]. However,
this enrichment would be expected to be consistent and
not a significant variable factor among in situ samples ana-
lyzed simultaneously (i.e. Figure 4A-B) making the PS4≡
probe suitable for interrogating enzyme activity in their
native cellular environment.
Identification of labeled polypeptides in Huh-7 cells
To identify the enzymes labeled by the PS4≡ probe, the
combination of fluorescence 2D-gel electrophoresis (2D-
GE) and tandem mass spectrometry was used as
Figure 3 PS4≡ protein profiling is activity specific in hepatoma Huh-7 cells. The active proteome (200 μg) isolated from naïve Huh-7 cells
(B) and Huh-7 cells stably replicating HCV (C) was labeled in vitro for 1 h at 37°C with 20 μM of PS4≡ probe. A representative gel of the
denaturing preheating step of 100°C for 5 min (Δ) was performed as a control (A) to confirm the PS4≡ probe specificity toward active enzymes.
After separation of the proteomes by two-dimensional gel electrophoresis, the fluorescent-tagged proteins were scanned for fluorescence (A - C)
and subjected to silver staining (D - F). The labeled proteins, indicated with arrows, were compared with in situ profiling (Figure 4) and sent for
identification by LC-MS/MS (Table 1). The other unmarked fluorescent spots were considered non-specific background as they didn’t meet the
inclusion criteria of a MASCOT score above 50, a corresponding pI and molecular weight, as well as being identified in at least three
independent experiments. (G) The differential activity of fluorescently-labeled proteins in vitro was quantified with the ImageJ software (NIH) by
measuring the fluorescence intensity (normalized for volume) of the corresponding protein spot of HCV replicating Huh-7 cells (C) versus of that
of naïve Huh-7 cells (B). Statistically significant differences were determined using ANOVA, with probabilities *p < 0.05.
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Page 5 of 15Table 1 Identification of labeled proteins with the PS probe from Figures 3 and 4.
Gel
band*
Protein Function Accession
no. (NCBI)
Mass
(kDa)
pI MASCOT
score**
Sequence
coverage
(%)
Peptide sequence
1 Protein disulfide isomerase-
associated 4
Isomerase 4758304 72.89 4.96 57 3.4 -FDVSGYPTIK
-IDATSASVLASR
2 Heat shock 70 kDa protein 5 Chaperone 16507237 72.29 5.07 929 36.2 -VMEHFIK
-VLEDSDLK
-LTPEEIER
-ITITNDQNR
-DAGTIAGLNVMR
-VEIIANDQGNR
-DAGTIAGLNVMR + Ox. of M
-FEELNMDLFR
-NELESYAYSLK
-ELEEIVQPIISK
-TWNDPSVQQDIK
-SDIDEIVLVGGSTR
-TFAPEEISAMVLTK
-TFAPEEISAMVLTK + Ox. of
M
-ITPSYVAFTPEGER
-IINEPTAAAIAYGLDK
-NQLTSNPENTVFDAK
-SQIFSTASDNQPTVTIK
-LYGSAGPPPTGEEDTAEKDEL
3 Heat shock 70 kDa protein 8
isoform 1
Chaperone 5729877 70.85 5.37 767 32.5 -ITITNDK
-LSKEDIER
-FELTGIPPAPR
-DAGTIAGLNVLR
-VEIIANDQGNR
-YKAEDDLQR
-MVNHFIAEFK
-FEELNADLFR
-NSLESYAFNMK + Ox. of M
-SQIHDIVLVGGSTR
-TTPSYVAFTDTER
-SFYPEEVSSMVLTK
-NQVAMNPTNTVFDAK
-IINEPTAAAIAYGLDK
-NQVAMNPTNTVFDAK + Ox.
of M
-STAGDTHLGGEDFDNR
-TVTNAVVTVPAYFNDSQR
4 Heat shock 70 kDa protein 9 Chaperone 12653415 73.68 6.03 665 22.2 -VLENAEGAR
-RYDDPEVQK
-QAASSLQQASLK
-DAGQISGLNVLR
-VQQTVQDLFGR
-AQFEGIVTDLIR
-SDIGEVILVGGMTR
-TTPSVVAFTADGER
-LYSPSQIGAFVLMK
-QAVTNPNNTFYATK
-LLGQFTLIGIPPAPR
-NAVITVPAYFNDSQR
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Page 6 of 15Table 1: Identification of labeled proteins with the PS probe from Figures 3 and 4. (Continued)
Gel
band*
Protein Function Accession
no. (NCBI)
Mass
(kDa)
pI MASCOT
score**
Sequence
coverage
(%)
Peptide sequence
5 Vimentin Structural,
filament
340219 53.68 5.03 487 24.5 -QVDQLTNDK
-DNLAEDIMR
-QDVDNASLAR
-FADLSEAANR
-VELQELNDR
-EYQDLLNVK
-ILLAELEQLK
-LGDLYEEEMR
-NLQEAEEWYK
-SLYASSPGGVYATR
-ISLPLPNFSSLNLR
6 Prolyl 4-hydroxylase, beta subunit
precursor (Protein disulfide
isomerase)
Isomerase
(chaperone)
20070125 57.08 4.76 619 28.5 - FFPASADR
- QLAPIWDK
- ENLLDFIK
- LKAEGSEIR
- VHSFPTLK
- ILEFFGLK
- THILLFLPK
- EADDIVNWLK
- LITLEEEMTK
- NFEDVAFDEK
- MDSTANEVEAVK + Ox. of
M
- YQLDKDGVVLFK
- VDATEESDLAQQYGVR
- HNQLPLVIEFTEQTAPK
7 Alpha 2-HS-glycoprotein Ion binding 156523970 39.33 5.43 136 6.3 -HTLNQIDEVK
-CDSSPDSAEDVRK
8 ATP synthase beta subunit Hydrolase 1374715 51.17 4.92 541 32.6 -IGLFGGAGVGK
-IPVGPETLGR
-VVDLLAPYAK
-TIAMDGTEGLVR
-TIAMDGTEGLVR + Ox. of M
-IMNVIGEPIDER
-IMNVIGEPIDER + Ox. of M
-FTQAGSEVSALLGR
-TVLIMELINNVAK
-VALVYGQMNEPPGAR
-VALVYGQMNEPPGAR + Ox.
of M
-AIAELGIYPAVDPLDSTSR
9 Protein disulfide isomerase A5 Isomerase 1710248 46.17 4.95 357 15.6 -AATALKDVVK
-GESPVDYDGGR
-TGEAIVDAALSALR
-NLEPEWAAAASEVK
-LAAVDATVNQVLASR
-GSTAPVGGGAFPTIVER
10 Quinolinate phosphoribosyl-
transferase
Transferase 13477197 30.81 5.82 109 11.4 -YDLGGLVMVK
-DNHVVAAGGVEK
-YGLLVGGAASHR
11 Nucleobindin Ion binding 189308 53.70 5.15 62 2.8 -LVTLEEFLASTQR
12 Phosphoglycerate dehydrogenase Oxidoreductase 5771523 56.63 6.29 196 10.5 - TLGILGLGR
- GGIVDEGALLR
- VTADVINAAEK
- ILQDGGLQVVEK
- GTIQVITQGTSLK
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Page 7 of 15outlined in Figure 1C. Fluorescence 2D-GE was chosen
over multidimensional protein identification technology
(MudPIT) for its high throughput quantitative analysis
and topological protein information, in spite of lower
protein detection and higher signal overlap from co-
migrating background proteins, which are two potential
limiting factors for 2D-GE [14].
In vitro and in situ ABPP of the active proteome from
naïve Huh-7 cells and cells stably replicating HCV, ana-
lyzed by 2D-GE and LC-MS/MS, revealed 19 reactive
candidates whose labeling were abolished when sub-
jected to in vitro pre-denaturation step (Δ)a t1 0 0 ° Cf o r
5 min (Figure 3). These candidates were considered
positive hits, providing that they had a MASCOT score
above 50, a corresponding pI and mass during 2D-GE
migration, and reproducible identification in at least
three independent experiments (Table 1). Due to the
lack of eligibility criteria or reproducible identification,
the other unmarked fluorescent spots were considered
as non-specific background or co-migrating contami-
nants and were not further analyzed (data not shown).
Aside from the pre-denaturation step (Figure 2A, 3A),
the activity dependent PS4≡ labeling is supported by the
presence of known phenyl sulfonate targets in the reac-
tive candidates, such as aldehyde dehydrogenase 1, for
which the labeling has been shown to be blocked by the
inhibitor disulfiram [28] and the cofactor NAD
+ [21],
which suggests activity-dependent probe reactivity and
cofactor-binding selectivity of targeted enzymes.
Furthermore, mass spectroscopy analyses confirmed the
binding of the PS4≡ probe to the catalytic pocket of the
enzymes. Mutations of those catalytic residues abolished
more than 90% the PS4≡ labeling compared to their
wild-type counterpart [27]. In a catalytic assay, the
probe (i.e. irreversible inhibitor)-bound wild-type tar-
geted enzyme demonstrated more than a 90% reduction
in activity toward its endogenous substrate [27]. These
inhibition-based experiments validate the active-state
specificity of the PS4≡ probe labeling toward its protein
targets.
Characterization of the PS4≡ probe targets
The 19 PS4≡ probe targets were grouped into their
respective protein families (Table 1, Figure 5A) where
the majority of the candidates corresponded to enzyme
classes previously labeled with phenyl sulfonate ester
probes, including hydrolases, transferases, oxidoreduc-
tases, and isomerases [20,21,27,28,31]. Some of our
Huh-7 PS4≡ hits were previously identified with phenyl
sulfonate probes in human breast cancer cells and in
vivo mouse models, such as aldehyde dehydrogenase 1
[20,27,28,32] and protein disulfide isomerase (i.e. prolyl
4-hydroxylase) [28], thereby validating our non-directed
ABPP methodology in human hepatoma cells. The
Table 1: Identification of labeled proteins with the PS probe from Figures 3 and 4. (Continued)
Gel
band*
Protein Function Accession
no. (NCBI)
Mass
(kDa)
pI MASCOT
score**
Sequence
coverage
(%)
Peptide sequence
13 Aldehyde dehydrogenase 1 Oxidoreductase 2183299 54.80 6.30 293 11.0 - ILDLIESGK
- VAFTGSTEVGK
- QAFQIGSPWR
- EEIFGPVQQIMK + oxid(M)
- IFVEESIYDEFVR
14 Nuclear distribution gene C
homolog
Protein binding 5729953 38.22 5.27 87 6.0 -SETSGPQIK
-LVSSDPEINTK
15 Cytokine induced protein 29 kDa Nucleotide,
protein binding
32129199 23.66 6.10 66 9.0 -FGISSVPTK
-ITSEIPQTER
16 Endoplasmic reticulum protein 29
isoform 1
Chaperone 5803013 28.97 6.77 269 25.7 - QGQDNLSSVK
- SLNILTAFQK
- FDTQYPYGEK
- ESYPVFYLFR
- GALPLDTVTFYK
- DGDFENPVPYTGAVK
17 Proteasome subunit alpha type-1 Hydrolase 190447 30.21 6.51 143 10.6 -LVSLIGSK
-ILHVDNHIGISIAGLTADAR
18 Purine nucleoside phosphorylase Transferase 230387 32.13 6.45 84 9.7 -FEVGDIMLIR
-LGADAVGMSTVPEVIVAR
19 Electron transfer flavoprotein,
alpha polypeptide
Electron
transport
4503607 35.06 8.62 156 16.5 -SPDTFVR
-LEVAPISDIIAIK
-GLLPEELTPLILATQK
-AAVDAGFVPNDMQVGQTGK
*P S 4 ≡ probe labeled protein bands numbered in Figures 3 and 4.
** MASCOT minimal protein score = 50.
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Page 8 of 15Figure 4 In situ PS4≡ protein profiling during HCV replication identifies nine differentially active proteins. The PS4≡ probe was added to
the cellular media of naïve Huh-7 cells (A) or Huh-7 stably expressing the HCV replicon (B) for 1 h at 37°C. The labeled proteome was isolated
and subjected to Huisgen’s 1,3-dipolar cycloaddition with rhodamine azide. After separation of the proteomes by two-dimensional gel
electrophoresis, the fluorescently tagged proteins were scanned (A, B), silver stained (C, D), and identified by LC-MS/MS (Table 1). (E) The
differential activity between in situ (Figure 4) and in vitro (Figure 3) fluorescently labeled proteins in Huh-7 cells was quantified with the ImageJ
software (NIH) by measuring the fluorescence intensity (normalized for volume) of the corresponding protein spot. (F) The differential activity of
fluorescently labeled proteins between HCV and naïve Huh-7 cells was quantified with the ImageJ software (NIH) by measuring the fluorescence
intensity (normalized for volume) of the corresponding protein spot of HCV replicating Huh-7 cells (B) versus of that of naïve Huh-7 cells (A).
Statistically significant differences were determined using ANOVA, with probabilities *p < 0.05.
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Page 9 of 15remaining candidates represent novel PS4≡ targets
(Table 1). The variety of the PS4≡ hits (nine protein
classes were identified in this study) (Figure 5A) could
be reflected by the diversity of amino acids known to be
labeled by the PS4≡ probe (aspartate, cysteine, gluta-
mate, and tyrosine) [27], which reveal the versatility of
the phenyl sulfonate reactive group in labeling a diver-
sity of catalytic residues in a range of mechanistically
distinct enzymes. Some proteins targeted in Huh-7 cells
were shown to utilize these amino acids as catalytic resi-
dues in their active pocket. For example, protein disul-
fide isomerases (spots 1, 6 and 9) have cysteine catalytic
residues [33] whereas phosphoglycerate dehydrogenase
(spot 12), aldehyde dehydrogenase 1 (spot 13), and pur-
ine nucleoside phosphorylase (spot 18) possess a cataly-
tic glutamate [34-36]. Both types of residues would
likely be covalently labeled by the PS4≡ probe [27].
Alternatively, several previously PS4≡ labeled enzymes
were shown not to utilize covalent catalysis [20,31], thus
suggesting a second labeling mechanism where a non-
catalytic residue (such as cysteine) in the active pocket
of non-enzymatic hits could serve as the site of labeling
by the PS4≡ probe [21]. The diversity of potential activ-
ity-based labeling mechanisms of the PS4≡ probe could
explain the broad range of proteins identified in Huh-7
cells (Table 1, Figure 5A).
In situ PS4≡ activity profiling during HCV replication
To assess the non-directed activity profile during HCV
replication, PS4≡ profiling was performed on naïve
Huh-7 cells and those stably replicating the pFK-
I389neo/NS3-3’/5.1 subgenomic HCV replicon
[26,37-42] at high levels [19]. Several PS4≡ targets
(Table 1), including aldehyde dehydrogenase 1, protein
disulfide isomerase, phosphoglycerate dehydrogenase,
heat shock protein 70 kDa protein 5, ATP synthase beta
subunit, and endoplasmic reticulum protein 29, were
also detected with amino acid coupled quinolimine
methide probes, confirming our previous findings [19]
and supporting the concept that non-directed ABPP
complements directed ABPP analysis through parallel
[19] or multiplexed experiments [20]. Interestingly,
HCV NS3/4A enzyme was not detected by the PS4≡
probe, even in vivo. Labeling experiments using a fluor-
ophosphonate and several substrate-based ABPP probes
on purified recombinant HCV NS3/4A showed reluc-
tance of the enzyme towards ABPP labeling [19]. This
lack of detection could be attributed to several factors,
including the low abundance of NS3/4A relative to
Figure 5 PS4≡ non-directed activity-based profiling targets several protein classes during HCV replication. (A) Compilation of the 19 true
probe targets from Figures 3 and 4 and classification into their corresponding protein family (data from Table 1). (B) Expression analysis of five
differentially active protein candidates: heat shock protein 70 kDa (HSP70), protein disulfide isomerase A1 (PDIA1), alpha 2-HS-glycoprotein
(AHSG), nuclear distribution gene C homolog (NUDC), and electron transfer flavoprotein alpha polypeptide (ETFA) (Figure 4 and Table 1). The
expression analysis was performed by western blotting in the naïve Huh-7 cell line and Huh-7 stably expressing the bi-cistronic pFK-I389neo/
NS3-3’/5.1 subgenomic replicon (HCV).
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Page 10 of 15other host cell hydrolase or product inhibition of the
enzyme [43].
Although heat shock 70 kDa protein 5 was also
labeled by both the PS4≡ and amino acid coupled qui-
nolimine methide probes in vitro [19], its activity was
significantly higher during HCV replication in situ when
compared to in vitro (Figure 4E, spot #2). The modest
decrease in activity, although not completely abolished,
of heat shock 70 kDa protein 5 after proteome extrac-
tion (Figure 4E, spot #2) suggests a potentially more
important role for this protein during HCV replication.
These observations further outline the benefits of in situ
profiling of proteins in their native cellular environment
to obtain their accurate activity in presence of their cel-
lular endogenous inhibitors/activators.
To examine if the fluorescence intensity difference
observed during HCV replication could solely be attrib-
uted to differential enzymatic activity or could reflect
differences in gene expression, the expression levels of
five protein candidates identified by non-directed ABPP
during HCV replication were analyzed by western blot-
ting (Figure 5B). Both AHSG and ETFA differential
activity levels (Figure 4F) correlated with protein level
variations (Figure 5B) between naïve Huh-7 cells and
those stably replicating HCV thus suggesting that the
expression level of these genes is altered in Huh-7 stably
replicating HCV. The absence of any differential expres-
sion levels in the three remaining candidates (HSP70,
PDIA1 and NUDC) could be explained by the fact that
these enzymes display a differential activity during HCV
replication, while having unchanged protein levels. Post-
translational modifications or the HCV-mediated modu-
lation of endogenous inhibitors/activators or subcellular
localization could explain this observation.
Some PS4≡ identified candidates obtained from Huh-7
cells have been shown to be implicated in HCV or in
HCV-related liver complications. For example, heat
s h o c k7 0k D ap r o t e i n8( H S P 7 0 A 8o rH S P 7 0c o g n a t e )
was recently shown to associate with HCV core, E2 pro-
tein, and viral particles around lipid droplets (LDs) to
influence viral release and the abundance of cellular LDs
[44]. We recently showed LDs to be highly abundant in
Huh-7 cells with high levels of HCV pFK-I389neo/NS3-
3’/5.1 replication (unpublished observation), which
could explain the higher HSP70A8 activity (Figure 4F,
spot #3) resulting in more abundant LD and HSP70A8
aggregates [44]. Furthermore, the identified HSP70 pro-
teins 5, 8 and 9, along with aldehyde dehydrogenase 1,
vimentin, cytokine-induced protein 29 kDa, and electron
transfer flavoprotein alpha (ETFA), are known markers
and proteins of interest in HCV-associated hepatocellu-
lar carcinoma, cirrhosis and cellular interferon response
[45-52].
The association of protein disulfide isomerase A1 and
A4 activity (Figure 4, spots 1 and 6) with HCV replica-
tion levels was also observed with a novel origamicin
probe [39], which reinforces the fact that these enzymes
might catalyze cysteine oxidation and disulfide bond iso-
merization of HCV proteins, also known to be essential
for the infectivity of other viruses (e.g. HIV) [53].
Another PS4≡ target, alpha 2-HS-glycoprotein (AHSG),
was found to associate with the 3’-untranslated region
of the HCV genome, potentially regulating HCV replica-
tion [54]. The PS4≡ profiling, in addition, allowed us to
observe an increased activity of this protein, which
could be mediated by HCV replication in Huh-7 cells
(Figure 4, spot 7), suggesting a synergistic effect. Simi-
larly, ETFA, involved in the beta-oxidation of fatty acids
and the subsequent transfer of their electrons to the
electron transport chain of the inner mitochondrial
membrane, demonstrated a decreased activity during
HCV replication (Figure 4, spot 19). Hepatitis C virus
had been shown to inhibit mitochondrial electron trans-
port and to increase reactive oxygen species (ROS) in
vitro and in vivo [55], which correlates with the
observed PS4≡ labeling decrease of ETFA. Furthermore,
as this enzyme is part of the fatty acid catabolism (i.e.
beta-oxidation), its decreased activity during HCV repli-
cation could constitute an additional contributing factor
to abundant Huh-7 lipid accumulation and potentially
be a cause in HCV-mediated steatosis. To the best of
our knowledge, the remaining differentially active pro-
teins identified by PS4≡ during HCV replication, such as
protein disulfide isomerase A5 and nuclear distribution
gene C homolog, have not been studied so far in context
with HCV thus making the PS4≡ non-directed probe an
important tool in identifying novel host-pathogen inter-
actions. Further characterization of these enzymes will
be required to confirm their differential activities and
reveal their potential roles during HCV replication and
infectivity.
Conclusions
In situ ABPP using a PS4≡ probe identified 13 novel tar-
gets in Huh-7 cells replicating HCV RNA. Some, like
HSP70A8, have a known importance in HCV propaga-
tion [44]. Six additional PS4≡ protein targets were pre-
viously identified in Huh-7 cells with a directed amino
acid coupled quinolimine methide probe in vitro [19]
validating this study’s findings and methodology. Three
novel potentially important host protein activity changes
in the presence of replicating HCV involved proteins
ETFA, protein disulfide isomerase A5, and nuclear dis-
tribution gene C homolog. These findings suggest that
using both combinatorial and directed methods, either
separately or in combination, can accelerate the discov-
ery of protein activities associated with pathogenic states
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results highlight that in situ ABPP facilitates the probing
of activity-based protein profiles that are predominantly
or exclusively labeled in living cells. Furthermore, the
strategy allows for the rapid identification of differen-
tially active enzymes during HCV replication.
Methods
Chemical synthesis of PS4≡ probe, RhN3, and TBTA ligand
Synthesis of the PS4≡ probe, RhN3, and tris-(benzyltria-
zoylmethyl) amine (TBTA) ligand were performed as
described previously [28,56].
Tissue culture and reagents
The human hepatoma cell line Huh-7 was grown in
monolayers with DMEM medium supplemented with
100 nM nonessential amino acids, 50 U/mL penicillin,
50 μg/mL streptomycin, and 10% FBS (CANSERA, Rex-
dale, ON). The Huh-7 cells stably expressing the subge-
nomic replicons (Figure 1A) (genotype 1B, con1)
(passage number between 40 and 50) were maintained
in the same culture medium supplemented with 250 μg/
mL G418 Geneticin (GIBCO-BRL, Burlington, ON). The
pFK-I389neo/NS3-3’/5.1 subgenomic replicon (Figure
1A) was kindly provided by Ralf Bartenschlager (Insti-
tute of Hygiene, University of Heidelberg, Germany).
Active proteome extraction and in vitro activity based
profiling
Subconfluent cells (80-90%) were washed and pooled
with ice-cold 10 mM sodium phosphate buffer, pH 7.
The cells were then subjected to Dounce-homogeniza-
tion at 30% power (T8 Ika-Werke homogenizer, GMBH,
Staufen, Germany) and sonicated (20 pulses, 50% duty
cycle, Sonifier 250, Branson Ultrasonic, Danbury, CT) in
ice-cold sodium phosphate buffer supplemented with 1%
Triton X-100. The crude proteome extract was cleared
by ultra centrifugation at 100,000 g, 4°C for 45 min,
quantified with the BCA protein assay (Pierce, Rockford,
I L )a n dd i l u t e dw i t hs o d i u mp h o s p h a t eb u f f e rt oaf i n a l
protein concentration of 1 mg/mL. The in vitro active
proteome labeling conditions were optimized as follows
(Figure 2A): the proteome extract (1 mg/mL in sodium
phosphate buffer) was incubated in the dark with 20 μM
of PS4≡ probe (from a 100 mM stock in dimethyl sulf-
oxide (DMSO), final DMSO concentration of 0.02%) for
1 h at 37°C with occasional mixing. After one hour, the
reaction was quenched by precipitating the proteome
with acetone: five volumes of ice-cold acetone were
added to the sample, then the samples were frozen at
-80°C for 30 min and subsequently centrifuged at 15,000
g, 4°C for 15 min to remove salts and unreacted probe.
In situ PS4≡ protein profiling in Huh-7 hepatoma cells
The in situ active proteome labeling conditions were
o p t i m i z e d( F i g u r e2 B )t ot h efollowing: the cell culture
media of subconfluent cells (80-90%) was replaced with
fresh media containing 100 μMP S 4 ≡ probe (from a 100
mM stock in DMSO, final DMSO concentration of
0.1%) for 1 hr, 37°C, 5% CO2 in a cell culture incubator
to allow for cellular uptake and proteome labeling. The
cells were subsequently washed twice with ice-cold 10
mM sodium phosphate buffer, pH 7, and the proteome
was harvested by Dounce-homogenization and sonica-
tion as described above.
Bioorthogonal conjugation to RhN3 via cycloaddition
reaction
In vitro or in situ PS4≡ labeled proteomes precipitated
with acetone were resuspended in 200 μL distilled
water. Cycloaddition reagents were added sequentially:
200 μM RhN3 (2.6 mM stock in DMSO), 2 mM sodium
ascorbate (26 mM stock in water), and 200 μMT B T A
ligand (2.6 mM stock in 1:4 DMSO:t-butanol). Prior to
addition of the copper catalyst, the reaction mixture was
vortexed, and 2 mM CuSO4.5H2O( 2 6m Ms t o c ki n
water) was added. Samples were mixed and incubated at
25°C for 1 hour in the dark at room temperature. The
reaction was quenched by acetone precipitation as
described above.
2D analysis of labeled proteomes
Precipitated protein pellets (200 μg) were resuspended
in 125 μl of isoelectric focusing (IEF) buffer (7 M Urea,
2 M thiourea, 4% CHAPS, 1% DTT) containing 0.2%
Ampholytes pH 3-10 (biolytes, Bio-Rad, Hercules, CA).
IPG strips pH 3-10 NL, 7 cm (Bio-Rad) were passively
rehydrated with the resuspended proteomes for 16 h.
The rehydrated protein IPG strips were then submitted
to isoelectric focusing using the Protean IEF Cell (Bio-
Rad) with the following conditions: 200 V rapid ramp
for 30 min, 500 V rapid ramp for 30 min, 2 h linear
ramp to 6,500 V, and 2 h focusing (rapid ramp) at 6,500
V. The accumulated voltage-hour (VH) felt between a
range of 12,000 - 17,500 VH.
Prior to SDS-PAGE separation, proteins immobilized on
the IPG strips were reduced (1% DTT) and alkylated (4%
iodoacetamide) in SDS equilibration buffer (6 M urea, 30%
g l y c e r o l ,2 %S D S ,5 0m Mt r i s - H C l ,p H8 . 8 ) .T h eS D S -
PAGE separation was performed on a 10% gel (1.5 mm
thickness) at constant 150 V per gel. The gels were then
scanned for fluorescence using the Typhoon 9410 (GE
Healthcare, Piscataway, NJ) and were subsequently incu-
bated overnight in fixing solution (50% v/v Ethanol, 5% v/
v acetic acid). Finally, gels were stained with silver nitrate
and scanned using the Fluor-S imager (Bio-Rad) in order
to visualize the entire cellular proteome.
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The fluorescent gel image was aligned with the silver
stained gel image to locate the labeled protein spots.
Protein candidates displaying heat-sensitive activity were
selected as specific targets, while candidates showing
heat-insensitive reactivity were considered as non-speci-
fic targets. The selected spots were manually excised
under a laminar flow hood. Gels spots were destained
with potassium ferricyanide solution (15 mM potassium
ferricyanide, 50 mM sodium thiosulfate), rinsed three
times with water, and then shrunk with acetonitrile. The
gel pieces were reswelled with 20 μl of trypsin solution
(0.01 μg/μl in 50 mM ammonium bicarbonate) and
incubated overnight at 37°C.
Peptides were identified by LC-MS/MS on a LTQ XL
(Thermo) mass spectrometer. The LTQ XL mass spec-
trometer (Thermo) was coupled to a MDLC chromato-
graphy system (GE Healthcare). The samples were first
injected onto a 0.3 × 5 mm C18 micro pre-column car-
tridge (Dionex/LC Packings) to remove salts and other
soluble contaminants. Samples were then separated on a
5c m×7 5μm BioBasic C18, 5 μm particle, PicoFrit col-
umn (New Objective) with a flow rate of ~300 nL/minute
using a 30 minute gradient: 0-30% acetonitrile/0.1% for-
mic acid over 14 minutes, 30-50% acetonitrile/0.1% for-
mic acid over 14 minutes, 50-90% acetonitrile/0.1%
formic acid over 2 minutes. MS and MS/MS data were
collected in enhanced profile and normal centroid mode
(scan rate: 8,000 amu/sec, scan range: 400-1,600), respec-
tively. MS/MS was performed on the three most abun-
dant multiple-charged peaks for each MS scan.
Peak lists were generated using the default parameters
by Extract-MSN in BioWorksBrowser 3.2 (ThermoFisher).
LC-MS/MS spectra were searched against the National
Centre for Biotechnology Information non-redundant
database (October 16, 2006; 2,879,860 sequence entries;
1,012,985,077 residues) using Mascot daemon version 2.0
(Matrix Science, London, UK). Search parameters used for
queries were trypsin cleavage, ≤1 missed cleavages, ± 1.5-
Da peptide tolerance, ± 1.2-Da MS/MS tolerance, with no
fixed modifications and the following variable modifica-
tions: carbamidomethyl (Cys), oxidation (Met). The results
were then evaluated manually: protein identification
required a MASCOT score above 50, a corresponding pI
and mass according to their position after 2D gel electro-
phoresis, as well as being identified in at least three inde-
pendent experiments.
Northern analysis
Total RNA from subconfluent cells was isolated using
the RNeasy extraction kit (Qiagen) and 1 μgw a su s e d
to detect HCV replicon RNA and b-actin mRNA. Bioti-
nylated negative sense probes complementary to HCV
genome region 6648-7770 bp (NS5b) and b-actin
(GenBank accession numbers AJ242654 and X00351,
respectively) were synthesized using the MEGAscript T7
kit (Ambion, Foster City, CA), biotin-11-UTP and bio-
tin-11-CTP (PerkinElmer, Boston, MA) following the
supplier’s protocol. Northern blotting and hybridization
were performed using the NorthernMax kit (Ambion)
and Hybond XL nylon membranes (Amersham Bios-
ciences, Piscataway, NJ). The bound riboprobes were
detected with the Chemiluminescent Nucleic Acid
Detection Module (Pierce, Rockford, IL).
Western immunoblotting
Proteomes (40 μg protein) were resuspended in SDS
loading buffer, resolved by SDS-PAGE under reducing
conditions (10% resolving gel), and transferred onto
Hybond-P PVDF membrane (Amersham Biosciences).
Thereafter, the membrane was blocked for 1 h in 5%
dried skim milk in Tris-buffered saline (TBS) with
0.05% Tween-20. Human HSP70, PDIA1, AHSG,
NUDC, ETFA, HCV NS5a, HCV NS3, and human b-
tubulin were targeted with: a mouse monoclonal anti-
HSP70 (1000-fold dilution in TBS-Tween; Abcam, Cam-
bridge, UK), a mouse monoclonal anti-PDIA1 (5000-fold
dilution in TBS-Tween, Abcam), a mouse monoclonal
anti-human fetuin A/AHSG (200-fold dilution in TBS-
Tween, R&D systems, Minneapolis, MN), a mouse
monoclonal anti-NUDC (1000-fold dilution in TBS-
Tween; Santa Cruz Biotechnology, Santa Cruz, CA), a
rabbit polyclonal anti-ETFA (500-fold dilution in TBS-
Tween; ProteinTech Group, Chicago, IL), a mouse
monoclonal anti-NS5a (0.2 μg/mL in TBS-Tween; Viro-
Stat, Portland, ME), a mouse monoclonal anti-NS3 (0.2
μg/mL in TBS-Tween; ViroStat), and a mouse monoclo-
nal anti-b-tubulin (3.5 μg/mL in TBS-Tween; Sigma),
respectively. After extensive washing, the membrane was
incubated for 1 h with the donkey anti-rabbit IgG horse-
radish peroxidase (HRP)-conjugated antibody (0.26 μg/
mL in TBS-Tween) or with the goat anti-mouse HRP-
conjugated antibody (0.8 μg/mL in TBS-Tween; Jackson
ImmunoResearch, West Grove, PA). Antigens were
detected using enhanced chemiluminescence (ECL Wes-
tern Blotting Detection Reagents; Amersham
Biosciences).
Statistical analysis
Individual experiments in this study were performed at
least in triplicate in order to confirm the reproducibility
of the results. Values are represented as means ± stan-
dard deviations. The statistical significance of differences
between two or more means was evaluated by using
analysis of variance (ANOVA); P values of less than 0.05
(indicated by asterisks) were considered to be statisti-
cally significant.
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